Related Experiment Video
Updated: Mar 11, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial Fibrillation and Risk of Dementia/Cognitive Decline
Anand D Shah1, Faisal M Merchant1, David B Delurgio1
1Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.
Insights
Atrial fibrillation (AF) increases dementia risk, partly via stroke but also inflammation and reduced brain blood flow. Medical and procedural treatments for AF may help prevent dementia.
Area of Science:
- Cardiology
- Neurology
- Gerontology
Background:
- Emerging evidence links atrial fibrillation (AF) to increased dementia risk.
- While cardioembolic stroke is a factor, other mechanisms like vascular inflammation and altered cerebral perfusion also contribute.
- Understanding these links is crucial for dementia prevention strategies.
Approach:
- This paper reviews current data on the association between AF and dementia syndromes.
- It explores the underlying pathophysiologic mechanisms.
- It evaluates the potential of medical and procedural therapies in mitigating dementia risk.
Key Points:
- Atrial fibrillation is an independent risk factor for dementia.
- Mechanisms include cardioembolic stroke, systemic inflammation, and hemodynamic changes affecting the brain.
- Anticoagulants, statins, and RAAS inhibitors are potential medical interventions.
- Catheter ablation and left atrial appendage closure are promising procedural options.
Conclusions:
- Atrial fibrillation poses a significant risk for dementia development.
- Targeting AF through medical and procedural interventions may offer a novel strategy for dementia risk reduction.
- Further research is warranted to optimize these therapies for neuroprotection.
Abstract:
Emerging evidence suggests a link between atrial fibrillation and subsequent development of dementia. While a majority of risk can be attributed to cardioembolic stroke secondary to atrial fibrillation, additional risk is apparent, and may be driven by vascular inflammation and changes in cerebral perfusion. Medical therapies including anticoagulation, statin therapy, and angiotensin-renin-aldosterone axis antagonists may reduce dementia risk. Procedural therapies such as atrial fibrillation catheter ablation and left atrial appendage closure may also prove to be important mediators of acute and long-term risk. In this paper, we review the data supporting a link between atrial fibrillation and dementia syndromes, pathophysiologic mechanisms and the potential roles of medical and procedural therapies at reducing such risk.
More Related Videos
Related Concept Videos
Dementia
The progression of dementia is generally gradual....
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias VI: Management of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

